Each year, thousands of patients worldwide receive CAR-T cell therapy for blood cancers, achieving remarkable success in treating previously incurable conditions. However, concerns about secondary ...
Targeted injection of mesenchymal precursor cells (MPCs) into the myocardium is safe but does not reduce recurrent nonfatal decompensated heart failure (HF) events in patients with chronic HF with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results